Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
about
Laser treatment of drusen to prevent progression to advanced age-related macular degenerationLaser treatment of drusen to prevent progression to advanced age-related macular degenerationAge-related macular degeneration--emerging pathogenetic and therapeutic concepts.Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen.Is drusen area really so important? An assessment of risk of conversion to neovascular AMD based on computerized measurements of drusen.Subthreshold Diode Micropulse Laser: A Review.Investigations into localized re-treatment of the retina with a 3-nanosecond laser.Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options.Effect of change in drusen evolution on photoreceptor inner segment/outer segment junction.Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.[Statement from the BVA, the DOG and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017].Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models.Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form
P2860
Q24186398-E493A113-D840-4D21-AA26-8B2133C78C95Q24240193-76CD6F1B-BF62-4A92-9ECC-2127439E25F3Q33263472-CB63F3A8-E158-4213-8268-5BA48DCEA673Q33771755-033EF38D-FF55-45D4-A5E5-A0271A026F25Q35929970-ABDE4D0B-5020-4C2A-A3F5-7E3C145552CCQ35950863-C405D495-19FA-42F4-889D-AF422FEBABF1Q36056327-8A147DEA-64C9-4622-A0BD-C260EC01D339Q36754160-F22213ED-DA68-41B5-A0D0-D8703983EFCFQ37616149-A925E987-BF34-45C8-A0A1-CDA51BE3551BQ37879178-45C5090A-121D-430E-993E-B6842A3EEFFBQ42086363-60AC100C-4AF8-427A-875E-BA062C043CA8Q47816363-323216C8-0774-4792-8D69-98AFD05F69F0Q49589259-34C5EE4A-A212-46BF-BCD2-658E51F1D86DQ55016413-8126E484-FFC4-4B26-A8C3-7E750CE78729Q58860417-7A6FC507-D3E9-403C-A4D5-6C21B227DFBA
P2860
Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Prophylactic treatment of age- ...... nilaterally eligible patients.
@ast
Prophylactic treatment of age- ...... nilaterally eligible patients.
@en
type
label
Prophylactic treatment of age- ...... nilaterally eligible patients.
@ast
Prophylactic treatment of age- ...... nilaterally eligible patients.
@en
prefLabel
Prophylactic treatment of age- ...... nilaterally eligible patients.
@ast
Prophylactic treatment of age- ...... nilaterally eligible patients.
@en
P2093
P1433
P1476
Prophylactic treatment of age- ...... Unilaterally eligible patients
@en
P2093
David C Musch
Jennifer I Lim
PTAMD Study Group
Steven Sinclair
Thomas R Friberg
William Freeman
P304
P356
10.1016/J.OPHTHA.2005.10.066
P577
2006-04-01T00:00:00Z